Global and China Gaucher Disease Treatment Market Size, Status and Forecast 2020-2026

SKU ID :QYR-16365065 | Published Date: 03-Sep-2020 | No. of pages: 93
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gaucher Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Type 1 (Neuropathic Forms) 1.2.3 Type 2 (Perinatal Lethal Form) 1.2.4 Type 3 (Slow-neurologic Decay Form) 1.3 Market by Application 1.3.1 Global Gaucher Disease Treatment Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Clinical Research Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gaucher Disease Treatment Market Perspective (2015-2026) 2.2 Global Gaucher Disease Treatment Growth Trends by Regions 2.2.1 Gaucher Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gaucher Disease Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Gaucher Disease Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gaucher Disease Treatment Players by Market Size 3.1.1 Global Top Gaucher Disease Treatment Players by Revenue (2015-2020) 3.1.2 Global Gaucher Disease Treatment Revenue Market Share by Players (2015-2020) 3.2 Global Gaucher Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gaucher Disease Treatment Revenue 3.4 Global Gaucher Disease Treatment Market Concentration Ratio 3.4.1 Global Gaucher Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gaucher Disease Treatment Revenue in 2019 3.5 Key Players Gaucher Disease Treatment Area Served 3.6 Key Players Gaucher Disease Treatment Product Solution and Service 3.7 Date of Enter into Gaucher Disease Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gaucher Disease Treatment Breakdown Data by Type (2015-2026) 4.1 Global Gaucher Disease Treatment Historic Market Size by Type (2015-2020) 4.2 Global Gaucher Disease Treatment Forecasted Market Size by Type (2021-2026) 5 Gaucher Disease Treatment Breakdown Data by Application (2015-2026) 5.1 Global Gaucher Disease Treatment Historic Market Size by Application (2015-2020) 5.2 Global Gaucher Disease Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gaucher Disease Treatment Market Size (2015-2026) 6.2 North America Gaucher Disease Treatment Market Size by Type (2015-2020) 6.3 North America Gaucher Disease Treatment Market Size by Application (2015-2020) 6.4 North America Gaucher Disease Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Gaucher Disease Treatment Market Size (2015-2026) 7.2 Europe Gaucher Disease Treatment Market Size by Type (2015-2020) 7.3 Europe Gaucher Disease Treatment Market Size by Application (2015-2020) 7.4 Europe Gaucher Disease Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Gaucher Disease Treatment Market Size (2015-2026) 8.2 China Gaucher Disease Treatment Market Size by Type (2015-2020) 8.3 China Gaucher Disease Treatment Market Size by Application (2015-2020) 8.4 China Gaucher Disease Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Gaucher Disease Treatment Market Size (2015-2026) 9.2 Japan Gaucher Disease Treatment Market Size by Type (2015-2020) 9.3 Japan Gaucher Disease Treatment Market Size by Application (2015-2020) 9.4 Japan Gaucher Disease Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Gaucher Disease Treatment Market Size (2015-2026) 10.2 Southeast Asia Gaucher Disease Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia Gaucher Disease Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia Gaucher Disease Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott Gaucher Disease Treatment Introduction 11.1.4 Abbott Revenue in Gaucher Disease Treatment Business (2015-2020)) 11.1.5 Abbott Recent Development 11.2 Aptalis Pharma 11.2.1 Aptalis Pharma Company Details 11.2.2 Aptalis Pharma Business Overview 11.2.3 Aptalis Pharma Gaucher Disease Treatment Introduction 11.2.4 Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2015-2020) 11.2.5 Aptalis Pharma Recent Development 11.3 Genzyme Corporation 11.3.1 Genzyme Corporation Company Details 11.3.2 Genzyme Corporation Business Overview 11.3.3 Genzyme Corporation Gaucher Disease Treatment Introduction 11.3.4 Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2015-2020) 11.3.5 Genzyme Corporation Recent Development 11.4 GlaxoSmithKline (GSK) 11.4.1 GlaxoSmithKline (GSK) Company Details 11.4.2 GlaxoSmithKline (GSK) Business Overview 11.4.3 GlaxoSmithKline (GSK) Gaucher Disease Treatment Introduction 11.4.4 GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2015-2020) 11.4.5 GlaxoSmithKline (GSK) Recent Development 11.5 Pfizer Inc 11.5.1 Pfizer Inc Company Details 11.5.2 Pfizer Inc Business Overview 11.5.3 Pfizer Inc Gaucher Disease Treatment Introduction 11.5.4 Pfizer Inc Revenue in Gaucher Disease Treatment Business (2015-2020) 11.5.5 Pfizer Inc Recent Development 11.6 Shire Human Genetic Therapies 11.6.1 Shire Human Genetic Therapies Company Details 11.6.2 Shire Human Genetic Therapies Business Overview 11.6.3 Shire Human Genetic Therapies Gaucher Disease Treatment Introduction 11.6.4 Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2015-2020) 11.6.5 Shire Human Genetic Therapies Recent Development 11.7 Eli Lilly and Company 11.7.1 Eli Lilly and Company Company Details 11.7.2 Eli Lilly and Company Business Overview 11.7.3 Eli Lilly and Company Gaucher Disease Treatment Introduction 11.7.4 Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2015-2020) 11.7.5 Eli Lilly and Company Recent Development 11.8 Enobia Pharma Inc 11.8.1 Enobia Pharma Inc Company Details 11.8.2 Enobia Pharma Inc Business Overview 11.8.3 Enobia Pharma Inc Gaucher Disease Treatment Introduction 11.8.4 Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2015-2020) 11.8.5 Enobia Pharma Inc Recent Development 11.9 Anthera Pharmaceuticals 11.9.1 Anthera Pharmaceuticals Company Details 11.9.2 Anthera Pharmaceuticals Business Overview 11.9.3 Anthera Pharmaceuticals Gaucher Disease Treatment Introduction 11.9.4 Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2015-2020) 11.9.5 Anthera Pharmaceuticals Recent Development 11.10 BioMarin Pharmaceutical 11.10.1 BioMarin Pharmaceutical Company Details 11.10.2 BioMarin Pharmaceutical Business Overview 11.10.3 BioMarin Pharmaceutical Gaucher Disease Treatment Introduction 11.10.4 BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2015-2020) 11.10.5 BioMarin Pharmaceutical Recent Development 11.11 MedPro Rx 10.11.1 MedPro Rx Company Details 10.11.2 MedPro Rx Business Overview 10.11.3 MedPro Rx Gaucher Disease Treatment Introduction 10.11.4 MedPro Rx Revenue in Gaucher Disease Treatment Business (2015-2020) 10.11.5 MedPro Rx Recent Development 11.12 Zymenex A/S 10.12.1 Zymenex A/S Company Details 10.12.2 Zymenex A/S Business Overview 10.12.3 Zymenex A/S Gaucher Disease Treatment Introduction 10.12.4 Zymenex A/S Revenue in Gaucher Disease Treatment Business (2015-2020) 10.12.5 Zymenex A/S Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Gaucher Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Type 1 (Neuropathic Forms) Table 4. Key Players of Type 2 (Perinatal Lethal Form) Table 5. Key Players of Type 3 (Slow-neurologic Decay Form) Table 6. Global Gaucher Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 7. Global Gaucher Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 8. Global Gaucher Disease Treatment Market Size by Regions (2015-2020) (US$ Million) Table 9. Global Gaucher Disease Treatment Market Share by Regions (2015-2020) Table 10. Global Gaucher Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 11. Global Gaucher Disease Treatment Market Share by Regions (2021-2026) Table 12. Gaucher Disease Treatment Market Market Trends Table 13. Gaucher Disease Treatment Market Drivers Table 14. Gaucher Disease Treatment Market Challenges Table 15. Gaucher Disease Treatment Market Restraints Table 16. Global Gaucher Disease Treatment Revenue by Players (2015-2020) (US$ Million) Table 17. Global Gaucher Disease Treatment Market Share by Players (2015-2020) Table 18. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2019) Table 19. Global Gaucher Disease Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Gaucher Disease Treatment Product Solution and Service Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 24. Global Gaucher Disease Treatment Market Size Share by Type (2015-2020) Table 25. Global Gaucher Disease Treatment Revenue Market Share by Type (2021-2026) Table 26. Global Gaucher Disease Treatment Market Size Share by Application (2015-2020) Table 27. Global Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 28. Global Gaucher Disease Treatment Market Size Share by Application (2021-2026) Table 29. North America Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 30. North America Gaucher Disease Treatment Market Share by Type (2015-2020) Table 31. North America Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 32. North America Gaucher Disease Treatment Market Share by Application (2015-2020) Table 33. North America Gaucher Disease Treatment Market Size by Country (US$ Million) (2015-2020) Table 34. North America Gaucher Disease Treatment Market Share by Country (2015-2020) Table 35. Europe Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 36. Europe Gaucher Disease Treatment Market Share by Type (2015-2020) Table 37. Europe Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 38. Europe Gaucher Disease Treatment Market Share by Application (2015-2020) Table 39. Europe Gaucher Disease Treatment Market Size by Country (US$ Million) (2015-2020) Table 40. Europe Gaucher Disease Treatment Market Share by Country (2015-2020) Table 41. China Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 42. China Gaucher Disease Treatment Market Share by Type (2015-2020) Table 43. China Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 44. China Gaucher Disease Treatment Market Share by Application (2015-2020) Table 45. China Gaucher Disease Treatment Market Size by Region (US$ Million) (2015-2020) Table 46. China Gaucher Disease Treatment Market Share by Region (2015-2020) Table 47. Japan Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 48. Japan Gaucher Disease Treatment Market Share by Type (2015-2020) Table 49. Japan Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 50. Japan Gaucher Disease Treatment Market Share by Application (2015-2020) Table 51. Japan Gaucher Disease Treatment Market Size by Country (US$ Million) (2015-2020) Table 52. Japan Gaucher Disease Treatment Market Share by Country (2015-2020) Table 53. Southeast Asia Gaucher Disease Treatment Market Size by Type (2015-2020) (US$ Million) Table 54. Southeast Asia Gaucher Disease Treatment Market Share by Type (2015-2020) Table 55. Southeast Asia Gaucher Disease Treatment Market Size by Application (2015-2020) (US$ Million) Table 56. Southeast Asia Gaucher Disease Treatment Market Share by Application (2015-2020) Table 57. Southeast Asia Gaucher Disease Treatment Market Size by Country (US$ Million) (2015-2020) Table 58. Southeast Asia Gaucher Disease Treatment Market Share by Country (2015-2020) Table 59. Abbott Company Details Table 60. Abbott Business Overview Table 61. Abbott Product Table 62. Abbott Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 63. Abbott Recent Development Table 64. Aptalis Pharma Company Details Table 65. Aptalis Pharma Business Overview Table 66. Aptalis Pharma Product Table 67. Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 68. Aptalis Pharma Recent Development Table 69. Genzyme Corporation Company Details Table 70. Genzyme Corporation Business Overview Table 71. Genzyme Corporation Product Table 72. Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 73. Genzyme Corporation Recent Development Table 74. GlaxoSmithKline (GSK) Company Details Table 75. GlaxoSmithKline (GSK) Business Overview Table 76. GlaxoSmithKline (GSK) Product Table 77. GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 78. GlaxoSmithKline (GSK) Recent Development Table 79. Pfizer Inc Company Details Table 80. Pfizer Inc Business Overview Table 81. Pfizer Inc Product Table 82. Pfizer Inc Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 83. Pfizer Inc Recent Development Table 84. Shire Human Genetic Therapies Company Details Table 85. Shire Human Genetic Therapies Business Overview Table 86. Shire Human Genetic Therapies Product Table 87. Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 88. Shire Human Genetic Therapies Recent Development Table 89. Eli Lilly and Company Company Details Table 90. Eli Lilly and Company Business Overview Table 91. Eli Lilly and Company Product Table 92. Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 93. Eli Lilly and Company Recent Development Table 94. Enobia Pharma Inc Business Overview Table 95. Enobia Pharma Inc Product Table 96. Enobia Pharma Inc Company Details Table 97. Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 98. Enobia Pharma Inc Recent Development Table 99. Anthera Pharmaceuticals Company Details Table 100. Anthera Pharmaceuticals Business Overview Table 101. Anthera Pharmaceuticals Product Table 102. Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 103. Anthera Pharmaceuticals Recent Development Table 104. BioMarin Pharmaceutical Company Details Table 105. BioMarin Pharmaceutical Business Overview Table 106. BioMarin Pharmaceutical Product Table 107. BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 108. BioMarin Pharmaceutical Recent Development Table 109. MedPro Rx Company Details Table 110. MedPro Rx Business Overview Table 111. MedPro Rx Product Table 112. MedPro Rx Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 113. MedPro Rx Recent Development Table 114. Zymenex A/S Company Details Table 115. Zymenex A/S Business Overview Table 116. Zymenex A/S Product Table 117. Zymenex A/S Revenue in Gaucher Disease Treatment Business (2015-2020) (US$ Million) Table 118. Zymenex A/S Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Gaucher Disease Treatment Market Share by Type: 2020 VS 2026 Figure 2. Type 1 (Neuropathic Forms) Features Figure 3. Type 2 (Perinatal Lethal Form) Features Figure 4. Type 3 (Slow-neurologic Decay Form) Features Figure 5. Global Gaucher Disease Treatment Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Clinical Research Institutes Case Studies Figure 9. Gaucher Disease Treatment Report Years Considered Figure 10. Global Gaucher Disease Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Gaucher Disease Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Gaucher Disease Treatment Market Share by Regions (2021-2026) Figure 13. Global Gaucher Disease Treatment Market Share by Players in 2019 Figure 14. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Gaucher Disease Treatment Revenue in 2019 Figure 16. North America Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Gaucher Disease Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Abbott Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 44. Aptalis Pharma Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 45. Genzyme Corporation Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 46. GlaxoSmithKline (GSK) Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 47. Pfizer Inc Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 48. Shire Human Genetic Therapies Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 49. Eli Lilly and Company Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 50. Enobia Pharma Inc Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 51. Anthera Pharmaceuticals Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 52. BioMarin Pharmaceutical Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 53. MedPro Rx Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 54. Zymenex A/S Revenue Growth Rate in Gaucher Disease Treatment Business (2015-2020) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed
Abbott Aptalis Pharma Genzyme Corporation GlaxoSmithKline (GSK) Pfizer Inc Shire Human Genetic Therapies Eli Lilly and Company Enobia Pharma Inc Anthera Pharmaceuticals BioMarin Pharmaceutical MedPro Rx Zymenex A/S
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients